FOR AUTHORS
Search
Search Results
Found 53 items.
-
Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients
Published: 17 March 20142493PDF: 1333 -
New approved drugs for psoriatic arthritis
Published: 9 September 20162963PDF: 2151 -
Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature
Published: 31 October 20136842PDF: 2454 -
The economic burden of musculoskeletal disorders on the Italian social security pension system estimated by a Monte Carlo simulation
Published: 16 September 20151969PDF: 1050 -
Intra-articular therapy with tumor necrosis factor-α antagonists: an update
Published: 14 March 20142469PDF: 1183 -
Influenza vaccination is safe and effective in patients suffering from fibromyalgia syndrome
Published: 16 September 20152070PDF: 1001 -
How much does an antiinflammatory treatment cost?
Published:1201PDF: 637 -
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?
Published: 29 January 2025201PDF: 67SUPPLEMENTARY MATERIAL: 12 -
Italian Society of Rheumatology recommendations for the management of gout
Published: 28 March 20135544PDF: 1492 -
Safety of lornoxicam in G-6-PDH deficiency
Published:733PDF: 532 -
BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS
Published:610PDF: 546 -
Efficacy and safety of Amtolmetin Guacyl in the symptomatic treatment of the osteoarthritis
Published:966PDF: 692 -
Discrepancies between clinical and pathological findings seen at renal biopsy in rheumatological diseases
Published: 18 September 20231129PDF: 468 -
Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with immunoglobulin G4-related disease
Published: 22 January 2025159PDF: 50SUPPLEMENTARY MATERIAL: 15 -
Safety of anti-TNFa biological drugs
Published:1097PDF: 1096 -
Are biological drugs safe in pregnancy?
Published: 31 March 20153560PDF: 2337 -
Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy
Published: 29 December 20221705PDF: 735 -
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
Published: 31 March 20152384PDF: 2215 -
A rare case of symptomatic creatine kinase elevation in a patient with rheumatoid arthritis treated with baricitinib
Published: 24 June 20241164PDF: 414 -
Intra-articular etanercept treatment for severe diffuse pigmented villonodular knee synovitis
Published:1489PDF: 2632 -
The treatment of recurrent uveitis with TNFα inhibitors
Published:1697PDF: 2312 -
Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice
Published:1148PDF: 669 -
Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)
Published:2002PDF: 1038 -
The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis
Published: 21 March 2023821PDF: 499 -
Baricitinib in polymyalgia rheumatica and giant cell arteritis: report of six cases
Published: 28 October 2024846PDF: 288 -
Treatment of Wegener’s granulomatosis
Published:1298PDF: 4964 -
Current therapeutic strategies for HCV-associated cryoglobulinemia
Published:1002PDF: 1966 -
Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies
Published:1005PDF: 1605 -
Psoriasis in women with psoriatic arthritis: hormonal effects, fertility, and considerations for management at different stages of life
Published: 11 September 20241797PDF: 520 -
Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report
Published:1124PDF: 849